Menu Back to Clinical-Trial-Disclosure-Towards-a-More-Transparent-World

Program Committee

  • Marla Jo  Brickman, PhD
    Marla Jo Brickman, PhD Senior Director - Clinical Data Transparency/Compassionate Access Lead
    Pfizer Inc, United States
  • Robert  Paarlberg, MS
    Robert Paarlberg, MS Principal
    Paarlberg & Associates LLC, United States
  • Mark  Barnes
    Mark Barnes Partner, Ropes & Gray LLP; Lecturer on Law, Harvard Law School
    Faculty Co-Director MRCT, Harvard University, United States
  • Christopher  Dedels
    Christopher Dedels
    Virtify, Inc, United States
  • Peter  Doshi, PhD
    Peter Doshi, PhD Postdoctoral Fellow in CER Divisions of Gen Pediatrics & Gen Internal Medicine
    Johns Hopkins University School of Medicine, United States
  • Jarilyn  Dupont, JD
    Jarilyn Dupont, JD Director of Regulatory Policy, Office of Policy, OC
    FDA, United States
  • Chris  Galvin
    Chris Galvin Office of Inspector General
    Department of Health and Human Services, United States
  • Jessica  Gilbart, MS
    Jessica Gilbart, MS Director of Patient Services
    Lupus Foundation of America, United States
  • Laura A. Hagan
    Laura A. Hagan Head of the Clinical Disclosure Office
    Novartis Pharmaceuticals Corporation, United States
  • Cheryl J. Jernigan
    Cheryl J. Jernigan Member, Advocates in Science Steering Committee
    Susan G. Komen For the Cure, United States
  • Michel  Krumenacker, MD
    Michel Krumenacker, MD Retired
    Retired - Formerly Sanofi, United States
  • Christine  Laine, MD, MPH
    Christine Laine, MD, MPH Senior Vice President; Editor, Annals of Internal Medicine
    American College of Physicians, United States
  • Rebecca  Li, PhD
    Rebecca Li, PhD Instructor, Harvard Medical; Executive Director, MRCT Clinical Trials Center
    Vivli Center for Global Clinical Research Data, United States
  • Ana  Rodriguez Sanchez Beato , PhD
    Ana Rodriguez Sanchez Beato , PhD Head of Clinical and Non-Clinical Compliance
    European Medicines Agency, European Union, United Kingdom
  • Joseph S. Ross, MD, MHS
    Joseph S. Ross, MD, MHS Assistant Professor of General Medicine and Public Health Policy
    Yale University School of Medicine, United States
  • Ahmed R. Saleh, PhD, MS
    Ahmed R. Saleh, PhD, MS Director, Clinical Trials; Laboratory of Viral Diagnostics
    University of Maryland, United States
  • Shannon  Tyson
    Shannon Tyson Manager, Clinical Trial Disclosure Group
    Pfizer Inc., United States
  • Sarah A White
    Sarah A White Director, Partners Human Research Quality Improvement Program
    Partners Healthcare, United States
  • Thomas  Wicks, MBA
    Thomas Wicks, MBA Chief Strategy Officer
    Trialscope, United States
  • Deborah A. Zarin, MD
    Deborah A. Zarin, MD Director,, National Library of Medicine
    National Institutes of Health (NIH), United States
  • Tracy  Beck
    Tracy Beck
    Eli Lilly and Company, United States
  • Barbara  Godlew, RN
    Barbara Godlew, RN Associate Consultant, Scientific Communications, GSC-Bio-Medicines
    Eli Lilly and Company, United States
  • Karen  Hartman, MSN, RN
    Karen Hartman, MSN, RN Research Compliance Officer
    Mayo Clinic, United States
  • Merete  Joergensen, MBA, MSc
    Merete Joergensen, MBA, MSc Senior Trial Disclosure Director, Global Clinical Registry
    Novo Nordisk A/S, Denmark
  • Erik  Lakes, MS, MSc
    Erik Lakes, MS, MSc Director, Clinical Study Disclosure
    PRA Health Sciences, United States
  • Hanns-Georg  Leimer, PhD
    Hanns-Georg Leimer, PhD Global Head Central Solutions and Services Medicine (CSSM) in Global Biostatisti
    Boehringer Ingelheim Pharma GmbH&CO KG, Germany
  • Melanie  North, PhD
    Melanie North, PhD Consultant
    Melanie North Consulting, United States
  • Patricia A. Teden, MBA
    Patricia A. Teden, MBA President and Principal
    Teden Consulting LLC, United States
Load More

Digital Learning Catalog

eLearning Catalog Cover